PTC, Inc. is a global software company, which engages in the provision of a portfolio of innovative digital solutions that work together to transform how physical products are engineered ...

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients ...

PTC India Limited (PTC) is a provider of power trading solutions in India. Its segments include Power and Financing business. The Power segment includes trading and generation of power. The ...

On a consolidated basis, net profit of PTC Industries surged 112.65% to Rs 17.31 crore while net sales rose 25.84% to Rs 72.37 crore in Q2 September 2024 over Q2 September 2023. Disclaimer: No ...

PTC Therapeutic's Upstaza gene therapy for patients with genetic disorder AADC deficiency has been recommended for approval in the EU, setting up another test of the commercial prospects for ...

PTC Therapeutics, Inc. (NASDAQ: PTCT) today provided an update on the Company's progress and its outlook for 2025. Matthew B. Klein, M.D., Chief Executive Officer of PTC, will discuss these updates at ...

PTC (Nasdaq: PTC), a global software company that enables manufacturers and product companies to digitally transform how they engineer, manufacture, and service the physical products that the ...

PTC India share price declined over 2% on Thursday to hit a 52-week low, after BlackRock reduced stake in the company. PTC India shares declined as much as 2.53% to touch a fresh 52-week low of ...

Analyst Joseph Schwartz from Leerink Partners reiterated a Hold rating on PTC Therapeutics (PTCT – Research Report) and increased the price target to $50.00 from $40.00. Don't Miss our Black ...